Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MRE3008F20 is a species-selective and potent adenosine A3 receptor (AA3R) antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used in glaucoma and asthma studies.CAS 번호13483-88-88-9
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 228.00 | |
25 mg | In stock | $ 388.00 | |
50 mg | In stock | $ 632.00 |
Description | MRE3008F20 is a species-selective and potent adenosine A3 receptor (AA3R) antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used in glaucoma and asthma studies.CAS 번호13483-88-88-9 |
Targets&IC50 | AA3 receptor (T lymphocytes):5 nM |
Molecular Weight | 432.44 |
Formula | C21H20N8O3 |
CAS No. | 252979-43-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MRE3008F20 252979-43-4 GPCR/G Protein Neuroscience cAMP Adenosine Receptor MRE-3008F20 inhibitor inhibit